In today’s briefing:
- Anthem Biosciences Pre-IPO: High Visibility Powered by Differentiated Capabilities
- 2025 Essential Calendar for Option Traders in Asia: Key Dates & Insights
Anthem Biosciences Pre-IPO: High Visibility Powered by Differentiated Capabilities
- Anthem Biosciences (1234D IN), a Contract Research, Development, and Manufacturing Organization, has filed DRHP for INR34B IPO. The proposed IPO will be only offer for sale, with no fresh issue.
- Anthem Biosciences is one of three CRDMOs that possess technological capabilities in India across ADCs, RNAi, peptides, and oligonucleotides, which are among the fastest growing in the pharmaceutical industry.
- Differentiated technological capabilities, large clientele, and exposure to commercialized molecules enhance our conviction on the sustainable growth prospect of the company. Industry backdrop is also favorable.
2025 Essential Calendar for Option Traders in Asia: Key Dates & Insights
- Timing expiration, assessing volatility, and managing event risk are crucial for effective option trades.
- Exchange holidays, expiries, central bank rate decisions, and index changes can significantly impact volatility and market direction.
- The attached document provides key dates to help navigate the complexities of option trading in Australia, Hong Kong, India, Japan, South Korea, and the USA.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
